Pacific 8 Ventures

Pacific 8 Ventures is a Taiwan-based venture capital firm, primarily focusing on healthcare and disruptive technology platforms. Founded by Jack Liang, the firm targets early-stage companies, with a preference for being the first institutional investor. Pacific 8 Ventures invests in transformative technologies, especially those reshaping therapeutics, diagnostics, and broader health services. Their investment approach is global, with a strong emphasis on the U.S. market, where disruptive healthcare innovations are burgeoning​. Pacific 8 Ventures has built a diverse portfolio of companies at the forefront of healthcare innovation. Notable investments include Mammoth Biosciences, known for its pioneering work with CRISPR technology, and BillionToOne, which revolutionizes prenatal testing. They have also invested in companies like Fauna Bio, which uses mammalian genetic data for novel therapeutics, and Dorian Therapeutics, focused on anti-aging technologies. The firm is also involved in significant collaborations, such as Mammoth Biosciences' $1 billion partnership with Bayer. Pacific 8 Ventures is dedicated to helping companies navigate the challenges of scaling in the competitive healthcare landscape, leveraging deep expertise and strategic support to drive success.